Armata Pharmaceuticals (ARMP) Free Cash Flow: 2013-2024
Historic Free Cash Flow for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to -$39.4 million.
- Armata Pharmaceuticals' Free Cash Flow fell 50.23% to -$3.6 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$11.2 million, marking a year-over-year decrease of 20.79%. This contributed to the annual value of -$39.4 million for FY2024, which is 29.04% up from last year.
- Latest data reveals that Armata Pharmaceuticals reported Free Cash Flow of -$39.4 million as of FY2024, which was up 29.04% from -$55.6 million recorded in FY2023.
- In the past 5 years, Armata Pharmaceuticals' Free Cash Flow registered a high of -$19.1 million during FY2020, and its lowest value of -$55.6 million during FY2023.
- Over the past 3 years, Armata Pharmaceuticals' median Free Cash Flow value was -$39.4 million (recorded in 2024), while the average stood at -$43.2 million.
- In the last 5 years, Armata Pharmaceuticals' Free Cash Flow crashed by 60.17% in 2023 and then increased by 29.04% in 2024.
- Over the past 5 years, Armata Pharmaceuticals' Free Cash Flow (Yearly) stood at -$19.1 million in 2020, then crashed by 30.30% to -$24.9 million in 2021, then slumped by 39.44% to -$34.7 million in 2022, then crashed by 60.17% to -$55.6 million in 2023, then increased by 29.04% to -$39.4 million in 2024.